Clinical & Experimental Metastasis is an international, multidisciplinary journal devoted to the rapid publication of fundamental advances in basic and applied metastasis research. The coverage encompasses all aspects of metastasis research, whether laboratory-based, experimental or clinical and therapeutic. It includes such areas as molecular biology, pharmacology, tumour biology, and clinical cancer treatment (with all its subdivisions of surgery, chemotherapy and radio-therapy as well as pathology and epidemiology) insofar as these disciplines are concerned with the journal's core subject of metastasis formation, prevention and treatment. Clinical & Experimental Metastasis is the official journal of the Metastasis Research Society.
Clinical & Experimental Metastasis
Description
Identifiers
ISSN | 0262-0898 |
e-ISSN | 1573-7276 |
DOI | 10.1007/10585.1573-7276 |
Publisher
Springer Netherlands
Additional information
Data set: Springer
Articles
Clinical & Experimental Metastasis > 2019 > 36 > 6 > 539-549
Breast cancer is one of the most prevalent malignancies in women, and approximately 75–80% of patients with advanced breast cancer develop bone metastasis. Expression of the cancer-associated carbohydrate antigen sialyl-Tn (STn) in breast cancer is associated with a poor prognosis; however, involvement of STn in the development of metastatic bone lesions remains unclear. We investigated whether STn...
Clinical & Experimental Metastasis > 2019 > 36 > 6 > 481-492
Metastasis, whether regional or distant, remains the main cause of morbidity and recurrence in oral cancer. The accumulating evidence suggests that inflammatory mediators are strong drivers for cancer progression and spread. However, the precise role of these inflammatory mediators in mediating specific metastatic stage is poorly understood due to lack of integration/validation of experimental research...